SEC 13F Intelligence

Beese Fulmer Investment Management, Inc. / ABT

Beese Fulmer Investment Management, Inc.’s Abbott Laboratories Position

Does Beese Fulmer Investment Management, Inc. own Abbott Laboratories (ABT)? Yes — 109.7K shares worth $11M (+0.72% of its 13F portfolio) as of Q1 2026, up from 109.5K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
109.7K
% of Portfolio
+0.72%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $8MQ3 ’19: $10MQ4 ’19: $10MQ4 ’19Q1 ’20: $9MQ2 ’20: $10MQ3 ’20: $12MQ4 ’20: $11MQ4 ’20Q1 ’21: $12MQ2 ’21: $11MQ3 ’21: $11MQ4 ’21: $13MQ4 ’21Q1 ’22: $11MQ2 ’22: $10MQ3 ’22: $9MQ4 ’22: $10MQ4 ’22Q1 ’23: $10MQ2 ’23: $10MQ3 ’23: $9MQ4 ’23: $10MQ4 ’23Q1 ’24: $11MQ2 ’24: $10MQ3 ’24: $11MQ4 ’24: $11MQ4 ’24Q1 ’25: $13MQ2 ’25: $14MQ3 ’25: $14MQ4 ’25: $14MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026109.7K$11M+0.72%
Q4 2025109.5K$14M+0.89%
Q3 2025106.6K$14M+0.99%
Q2 2025104.0K$14M+1.05%
Q1 2025101.4K$13M+1.16%
Q4 202495.0K$11M+0.92%
Q3 202495.4K$11M+0.93%
Q2 202495.9K$10M+0.91%
Q1 202495.2K$11M+1.02%
Q4 202394.4K$10M+1.08%
Q3 202394.0K$9M+1.03%
Q2 202394.6K$10M+1.12%
Q1 202395.6K$10M+1.11%
Q4 202295.6K$10M+1.26%
Q3 202294.2K$9M+1.23%
Q2 202291.9K$10M+1.28%
Q1 202291.6K$11M+1.18%
Q4 202192.7K$13M+1.36%
Q3 202194.2K$11M+1.25%
Q2 202196.6K$11M+1.27%
Q1 202199.5K$12M+1.43%
Q4 2020103.0K$11M+1.44%
Q3 2020106.1K$12M+1.63%
Q2 2020108.6K$10M+1.46%
Q1 2020114.4K$9M+1.60%
Q4 2019115.8K$10M+1.41%
Q3 2019114.3K$10M+1.44%
Q2 201997.1K$8M+1.55%
Q1 201998.3K$8M+1.55%
Q4 201897.7K$7M+1.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beese Fulmer Investment Management, Inc.’s full portfolio or all institutional holders of ABT.